What is a stock summary page? Click here for an overview.
Business Description
Equasens
ISIN : FR0012882389
Compare
Compare
Traded in other countries / regions
EQS.FrancePHF.Germany0R9T.UK IPO Date
2000-10-20Description
Equasens is engaged in the European healthcare sector, providing software solutions to all healthcare professionals (pharmacists, primary care practitioners, hospitals, Hospital-at-Home structures, retirement homes, health centres) and patients in both primary and secondary care sectors. With operations in France, Italy, Belgium, Luxembourg and the United Kingdom, Equasens is developing the healthcare platform and an ecosystem in France and Europe benefiting people by making available its technology services.
Financial Strength
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.79 | |||||
| Equity-to-Asset | 0.56 | |||||
| Debt-to-Equity | 0.32 | |||||
| Debt-to-EBITDA | 1.86 | |||||
| Interest Coverage | 91.97 | |||||
| Piotroski F-Score | 6/9 | |||||
| Altman Z-Score | 3.21 | |||||
| Beneish M-Score | -2.41 | |||||
| WACC vs ROIC | ||||||
Growth Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 8.6 | |||||
| 3-Year EBITDA Growth Rate | 8.8 | |||||
| 3-Year EPS without NRI Growth Rate | 15.8 | |||||
| 3-Year FCF Growth Rate | 12.6 | |||||
| 3-Year Book Growth Rate | 15.3 | |||||
| Future 3-5Y Total Revenue Growth Rate Estimate | 7.31 |
Momentum Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 27.94 | |||||
| 9-Day RSI | 34.37 | |||||
| 14-Day RSI | 37.47 | |||||
| 3-1 Month Momentum % | -13.76 | |||||
| 6-1 Month Momentum % | -20.13 | |||||
| 12-1 Month Momentum % | -25.99 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.22 | |||||
| Quick Ratio | 1.13 | |||||
| Cash Ratio | 0.51 | |||||
| Days Inventory | 104.7 | |||||
| Days Sales Outstanding | 79.35 | |||||
| Days Payable | 178.31 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 3.55 | |||||
| Dividend Payout Ratio | 0.4 | |||||
| 3-Year Dividend Growth Rate | 8.5 | |||||
| Forward Dividend Yield % | 3.55 | |||||
| 5-Year Yield-on-Cost % | 5.31 | |||||
| 3-Year Average Share Buyback Ratio | 0.1 | |||||
| Shareholder Yield % | 3.66 |
Profitability Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 85.13 | |||||
| Operating Margin % | 12.89 | |||||
| Net Margin % | 21.42 | |||||
| FCF Margin % | 17.88 | |||||
| ROE % | 23.38 | |||||
| ROA % | 12.56 | |||||
| ROIC % | 7.29 | |||||
| 3-Year ROIIC % | 13.14 | |||||
| ROC (Joel Greenblatt) % | 103.76 | |||||
| ROCE % | 11.23 | |||||
| Years of Profitability over Past 10-Year | 10 |
GF Value Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 11.42 | |||||
| Forward PE Ratio | 11.89 | |||||
| PE Ratio without NRI | 11.37 | |||||
| Shiller PE Ratio | 16.47 | |||||
| Price-to-Owner-Earnings | 12.39 | |||||
| PEG Ratio | 1.14 | |||||
| PS Ratio | 2.44 | |||||
| PB Ratio | 2.44 | |||||
| Price-to-Tangible-Book | 5.95 | |||||
| Price-to-Free-Cash-Flow | 13.73 | |||||
| Price-to-Operating-Cash-Flow | 9.35 | |||||
| EV-to-EBIT | 18.44 | |||||
| EV-to-EBITDA | 14.86 | |||||
| EV-to-Revenue | 2.51 | |||||
| EV-to-FCF | 14.17 | |||||
| Price-to-GF-Value | 0.4 | |||||
| Price-to-Projected-FCF | 0.93 | |||||
| Price-to-DCF (Earnings Based) | 0.56 | |||||
| Price-to-DCF (FCF Based) | 0.51 | |||||
| Price-to-Median-PS-Value | 0.44 | |||||
| Price-to-Peter-Lynch-Fair-Value | 1.12 | |||||
| Price-to-Graham-Number | 1.72 | |||||
| Earnings Yield (Greenblatt) % | 5.42 | |||||
| FCF Yield % | 7.43 | |||||
| Forward Rate of Return (Yacktman) % | 15.95 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return %
Total Annual Return %
Equasens Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 219.767 | ||
| EPS (TTM) (€) | 3.114 | ||
| Beta | 0.81 | ||
| 3-Year Sharpe Ratio | -0.58 | ||
| 3-Year Sortino Ratio | -0.73 | ||
| Volatility % | 34.97 | ||
| 14-Day RSI | 37.47 | ||
| 14-Day ATR (€) | 1.034068 | ||
| 20-Day SMA (€) | 36.9025 | ||
| 12-1 Month Momentum % | -25.99 | ||
| 52-Week Range (€) | 34.75 - 67.4 | ||
| Shares Outstanding (Mil) | 15.03 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 6 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Equasens Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Equasens Stock Events
| Event | Date | Price (€) | ||
|---|---|---|---|---|
| No Event Data | ||||
Equasens Frequently Asked Questions
What is Equasens(XPAR:EQS)'s stock price today?
The current price of XPAR:EQS is €35.20. The 52 week high of XPAR:EQS is €67.40 and 52 week low is €34.75.
When is next earnings date of Equasens(XPAR:EQS)?
The next earnings date of Equasens(XPAR:EQS) is .
Does Equasens(XPAR:EQS) pay dividends? If so, how much?
The Dividend Yield % of Equasens(XPAR:EQS) is 3.55% (As of Today), Highest Dividend Payout Ratio of Equasens(XPAR:EQS) was 0.48. The lowest was 0.34. And the median was 0.44. The Forward Dividend Yield % of Equasens(XPAR:EQS) is 3.55%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers